Nebraska AG Frees Doctors and Patients to Use HCQ and IVM

Ron Clutz's avatarScience Matters


Jim Hoft reports at Gateway Pundit Nebraska AG Issues Opinion on Doctors Prescribing HCQ and Ivermectin for COVID Treatment Will Not Face Punishment. Excerpts in italics with my bolds.

The Office of the Attorney General in Nebraska issued an opinion Friday in response to the request of the Nebraska Department of Health and Human Services that states there’s no “clear and convincingevidence that a physician who first obtains informed consent and then utilizes Ivermectin or hydroxychloroquine for COVID-19 violates the UCA (Nebraska’s Uniform Credential Act).”

Nebraska Attorney General Doug Peterson together with his Solicitor General and Assistant Attorney General issued their opinion in response to a request by Nebraska Department of Health and Human Services CEO, Dannette Smith. She wanted the AG’s office to examine carefully whether doctors could face legal action or be subject to discipline if they prescribed the meds for COVID treatment.

“Allowing physicians to consider…

View original post 928 more words

Stop Big Pharma Using Little Pharma Against Ivermectin

Ron Clutz's avatarScience Matters

For decades Big Pharma co-opted physicians to prescribe their products over those from competitors. The biggest winnings came when a new patent drug had no competition. And of course, when the patents run out, the generics take over the supply. With the Covid pandemonia, a new dynamic arose to protect vaccine profits against anti-viral generic drugs, especially HCQ and Ivermectin. Daniel Horowitz explains at Blaze Media Louisiana AG Jeff Landry warns pharmacies against blocking COVID treatment. Excerpts in italics with my bolds.

“Never have pharmacists been allowed to practice medicine and get between a doctor and his patient,”stated Louisiana Attorney General Jeff Landry in an interview with TheBlaze. “Most certainly not in middle of a pandemic.”

State attorney general might not be the elected position that comes to mind when assessing the pandemic response, but Landry believes that his counterparts in other states have a vital role to play…

View original post 742 more words

Ivermectin Safety Profile — The Wentworth Report

Ivermectin Safety Profile. By David Archibald. We have all heard the stories of ivermectin saving thousands of souls around the world every day, and countless more from debilitation and disfigurement by the dreaded Covid. 757 more words

Ivermectin Safety Profile — The Wentworth Report

CDC is misleading the public by reporting the per 100,000 rate instead of the actual percentages

CDC is misleading the public by reporting “per 100,000” rather than actual numbers. The chart above makes it look like the Native American population is being ravaged by Covid-19, but is misleading due to small percent of total population.

Per 100,000 is a rate, not an actual number. It is only good for comparing within a fixed population/ group, not between different sized populations/groups. This applies to different racial/ethnic groups, age groups, states, counties.  The smaller the total population, the larger the “per 100,000” appears.  If a population is 10 and only 1 is affected, that is 10,000 per 100,000.  If the population is 1000 and 1 is affected, that is 100 per 100,000. The technique magnifies results in smaller populations and reduces results in larger populations.

Example: January, 2021 data from USAfacts.org reported deaths per 100,000 by ethnic group. Each group has a different size and percent of total population.  Deaths per 100,000 is reported so that Native Americans appear to be the most affected by far because the population is relatively small.  See table below.

Ethnic GroupGroup PopulationGroup as Percent of US Pop.Covid Deaths per 100,000Number of Covid DeathsCovid Deaths as percent of total deaths
Native American6,371,2002285.118,1643.0
Black40,138,56012.6227.191,15415
Hispanic53,836,64016.9185.799,97516.5
White197,507,20062190.8376,84362
Asian16,565,1205.212320,3753.4

By converting the per 100,000 results reported into actual numbers and percentage of the total deaths, the picture is quite different and similar to the percent of US population for each group. The huge disparity has disappeared. Blacks and Native Americans appear to be slightly more affected, while Hispanics and Asian are slightly less affected than their population.

Epidemiology to take seriously: Natural immunity better than COVID vaccines — JunkScience.com

A new epidemiology study reports that natural immunity confers better protection against COVID than current vaccines. I’ve been publishing JunkScience.com for 25+ years and can’t think of a single epidemiology study I’ve seen that was worth anything. 31 more words

Epidemiology to take seriously: Natural immunity better than COVID vaccines — JunkScience.com
Original scientific paper from research team in Israel is attached. 

Israeli Study Conclusive: Natural Immunity Better Than Vaccinations

Media Hype about “Long Covid”

Ron Clutz's avatarScience Matters

Science Norway reports Poor studies on long Covid are sensationalized by the media  Excerpts in italics with my bolds.

Many recent reports in the media have given the impression that people are experiencing major long-term effects after having even mild Covid-19. This impression does not correspond with the knowledge we have accumulated so far.

We must dedramatise the long-term effects of Covid-19, often referred to as long Covid. The media have a responsibility in this regard. They must become more critical of the research methods used in the studies they refer to.

Most infectious diseases with severe symptoms will to some extent be accompanied by long-term effects. Most infectious diseases with mild symptoms will cause few short-term effects.

More and more studies are showing that this is probably also the case for Covid-19. It is vital that more high-quality studies are carried out to examine this problem.

Data…

View original post 379 more words

CDC dropping RT-PCR test for Covid-19

CDC is ending RT-PCR testing in favor of multiplex rapid antigen test to distinguish Covid from Flu. See CDC notice below. What they are not telling us is that the RT-PCR test has very high false positives, inflating the numbers. The rapid antigen test is more accurate and gives results in minutes, so medical care decisions can be made ASAP. Labs will start transitioning before the Dec 31, 2021 cutoff so numbers will start to drop, just in time for 2022 election year. England has been using the rapid antigen test for over a year.

07/21/2021: Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing

CDC's Laboratory Outreach Communication System (LOCS)

Audience: Individuals Performing COVID-19 Testing

Level: Laboratory Alert

After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.

Visit the FDA website for a list of authorized COVID-19 diagnostic methods. For a summary of the performance of FDA-authorized molecular methods with an FDA reference panel, visit this page.

In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.

Opt in to receive updates from the CDC Laboratory Outreach Communication System (LOCS).

Online resources:

If you have any questions, please contact us at LOCS@cdc.gov.

Thank you,

The Laboratory Outreach Communication System

Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)

Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)

Centers for Disease Control and Prevention (CDC)

LOCS@cdc.gov

www.cdc.gov/csels/dls/locs



https://www.cdc.gov/csels/dls/locs/2021/07-21-2021-lab-alert-Changes_CDC_RT-PCR_SARS-CoV-2_Testing_1.html

Why Is The CDC Quietly Abandoning The PCR Test For COVID?